---
schema_version: "secwatch.filing_event.v1"
accession: "0001639691-23-000108"
form_type: "8-K"
ticker: "LIVN"
cik: "0001639691"
company_name: "LivaNova PLC"
filed_at: "2023-11-01T23:59:59+00:00"
generated_at: "2026-06-09T02:45:13.626494+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# LivaNova Q3 revenue $286M (+13.3% YoY); raises full-year guidance

## Summary
- Revenue $286.1M, up 13.3% reported and 12.1% constant currency vs prior year.
- GAAP diluted loss per share $0.14; adjusted diluted EPS $0.73.
- Received FDA 510(k) clearance and CE Mark for Essenz In-Line Blood Monitor.
- Raised full-year 2023 revenue and adjusted diluted EPS guidance.
- Double-digit revenue growth across all regions and three business units.

## SEC filing metadata
- accession: 0001639691-23-000108
- form_type: 8-K
- ticker: LIVN
- cik: 0001639691
- company_name: LivaNova PLC
- filed_at: 2023-11-01T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1639691/000163969123000108/0001639691-23-000108-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1639691/000163969123000108/livn-20231101.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001639691-23-000108
- JSON: https://secwatch.observer/filing/0001639691-23-000108.json
- Plain text: https://secwatch.observer/filing/0001639691-23-000108.txt

## Key facts
- Earnings Releases
  LivaNova PLC reported the quarter ended September 30, 2023 results: revenue $286.1 million, EPS $0.73. Guidance raised.
  - Period: the quarter ended September 30, 2023
  - Revenue: $286.1 million
  - EPS: $0.73
  - Guidance: raised
  - Result: reported results
  source text: Third-quarter revenue of $286.1 million increased 13.3% on a reported basis and increased 12.1% on a constant-currency basis, as compared to the prior-year period
  evidence_url: https://www.sec.gov/Archives/edgar/data/1639691/000163969123000108/0001639691-23-000108-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.